Key facts
- Brightflow’s last known valuation is $24.8M.
- It has raised $20.7M; the latest was Early Stage VC ($18.3M) in Sep 2024.
- Notable investors include Bpifrance, UI Investissement, BNP Paribas Développement, GO Capital, Karista (Paris) — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Brightflow
- ·The full record, as it builds
Funding rounds
No funding rounds for Brightflow are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Brightflow
Developer of an implantable cardiac medical device designed to treat heart failures. The company provides concrete responses to doctors treating patients suffering from right-sided heart failure via innovative, percutaneous, minimally invasive, long-term devices, enabling patients to live longer and healthier lives.
- Sector
- Healthcare
- HQ
- Orleans, France
- Founded
- 2020
- Employees
- 6
- Website
- brightflow.com/
- Ownership
- Privately Held (backing)
Brightflow doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Brightflow shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Brightflow in its N-PORT filings yet. We sweep new filings monthly.